A mum whose teenage son died after being diagnosed with bone cancer has called for more awareness of the disease's symptoms.

Doctors also use the term bone sarcoma for primary bone cancer. On this page we use the term bone sarcoma. This is the same as primary bone cancer. The terms 1 year survival and 5 year survival don't ...

Promising Leiomyosarcoma Therapies such as Lurbinectedin, Doxorubicin, Unesbulin, Dacarbazine, Rucaparib, Nivolumab, ...

As per the National Cancer Institute, about 12,000 cases of soft tissue sarcomas and 3,000 cases of bone sarcomas are ...

Years after her cancer-related leg amputation, Ewing Sarcoma survivor Amanda Merrill has become a varsity basketball player and an inspiration to her friends and teammates. “Who cares if you’re ...

Sarcoma is one of the most aggressive and challenging cancers, with no significant advances in treatment or survival outcomes in over 30 years. It ...

Department of Neurosurgery, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China Background and importance: Leiomyosarcoma is a rare and aggressive malignant tumor ...

whether they are from a sarcoma or another type of cancer. The outlook for any STS depends on various factors, including the type and stage of the cancer. A 5-year relative survival rate predicts ...

Figure 4. Progression-Free Survival (PFS), according to duration of Trabectedin therapy, for STS patients in the study. <12M, Trabectedin therapy for less than 12 months; ≥12M, Trabectedin therapy for ...

The critical role of EZH2, an essential epigenetic regulator, in cancer progression and treatment is underscored in this new review article published in Genes & Diseases.